1. Introduction
The use of tobacco is the leading preventable risk factor for premature death in Western countries [
1]. While the prevalence of combustible tobacco products in the United States has declined from 42.4% in 1965 [
2] to 12.5% in 2020, there were still 30.8 million adults who smoke [
3]. Among youth, 1% of middle school children and 1.9% of high school children reported smoking in the past 30 days in 2021; and 2.8% of middle school children and 11.3% of high school children reported using electronic cigarettes (e-cigarettes) in the past 30 days in 2021 [
3]. Among adults, e-cigarette use was 3.7% in 2020 [
3]. Different formulations for tobacco and/or nicotine products are increasingly available, making people of younger or older age potentially dependent on a variety of products. Despite all efforts, tobacco use is still responsible for 20% of U.S. deaths (approximately 480,000 deaths) and shortens life expectancy by at least ten years [
3].
The good news, though, is that in a recent study, 68% of people who smoke cigarettes in the U.S. want to quit [
4]. In cessation research concerning e-cigarette use among youth, over half of the participants reported wanting to quit, and one-third made an attempt to quit within the previous year [
5]. The researchers did not indicate success rates for the youth who made the cessation attempts. Unfortunately, less than 10% of unaided abstinence attempts result in continued success [
4]. Combination counseling and evidence-based pharmacotherapy increase abstinence rates; however, less than 5% of people who want to quit receive behavioral counseling and tobacco cessation pharmacotherapy [
4]. Clinicians have identified a lack of tobacco treatment training as a roadblock to providing cessation services [
6].
These findings underline the need for effective interventions to assist with tobacco cessation. One powerful tool is the education of healthcare providers with evidence-based cessation strategies. This is critical as conventional products are changing and newer tobacco products are emerging.
Tobacco Treatment Specialist Training Programs (TTSTP) are educational programs for healthcare providers to have current, evidence-based knowledge and skills to encourage and assist with tobacco cessation. It was through the work of the Association for the Treatment of Tobacco Use and Dependence that the initial programs were developed and educational competencies established. Through an interprofessional effort, they formed a council (the Council for Tobacco Treatment Training Programs, or the CTTTP). In 2008 the Council developed a comprehensive approach to implementing evidence-based standards and supporting the growth of accredited programs across the U.S. Currently, there are 25 accredited programs. The goal of CTTTP is to educate healthcare participants to be able to aid people from diverse backgrounds in their tobacco cessation attempts. There are 11 competency requirements: (1) tobacco dependence knowledge and education; (2) counseling skills; (3) assessment skills; (4) treatment planning; (5) pharmacotherapy; (6) relapse prevention; (7) diversity and specific health issues; (8) documentation and evaluation; (9) professional resources; (10) laws and ethics; and (11) professional development.
The program helps healthcare to determine the intensity of treatment required to aid in tobacco cession intervention techniques. While many patients can be treated with low-intensity treatment, many individuals need high-intensity (combination) treatments to effectively address nicotine withdrawal, motivation, self-efficacy, and managing skills [
7]. For this reason, an emphasis in the program is pharmacotherapy in combination with counseling as neither by itself is as effective as in combination [
7]. Previous researchers indicated that healthcare providers have limited knowledge in delivering pharmacotherapy, counseling, and in providing high-intensity programs for tobacco users with high tobacco use and complex health issues [
8], indicating a need for such programs. However, there is limited information about how effective tobacco cessation treatment programs are. The purpose of this study was to evaluate a TTS training program after six months to determine if participants maintain knowledge and practices to help patients with tobacco cessation.
2. Methods
This study received West Virginia University Institutional Board approval as an exempt protocol, number 20039360. A mixed-method study design was used.
The study sample included professional healthcare registrants, ages ≥18 years, who provided consent and completed the May 2021 TTSTP. The sample included physicians, dentists, dental hygienists, nurses, advanced practice nurses, respiratory therapists, social workers, licensed professional counselors, and addiction counselors who were licensed or students in the healthcare field.
The TTSTP was a 3-day event with multiple interprofessional speakers and participants from medicine, dentistry, social work, pharmacy, nursing, and public health. The program involved lectures about conventional and newer tobacco and nicotine delivery systems, role-playing, group discussions, treatment planning, and relapse prevention. Participants were provided information on the use of the Fagerstrom Test for Nicotine Dependence (FTND), Heaviness of Smoking Index (HS), Hooked on Nicotine Check List (HONC), Fagerstrom Nicotine Dependence Scale—Smokeless Tobacco (FTND-ST), and the Penn State Nicotine Dependence Index. The pre-test and post-test questions were developed through a consensus of experts in tobacco cessation treatment and were a sample of the most meaningful and important aspects of knowledge and practices associated with tobacco cessation.
Participation in the research study was not a requirement for participation in the educational program. Participants were informed that the questions would involve their knowledge, skills, practices, and confidence in providing tobacco cessation assistance in Likert-style questions. Open-ended questions on the post-test were used for the qualitative aspect of the study.
The research was conducted using the Kirkpatrick Four Levels for Effective Evaluation of Training programs in which (1) participant reaction, (2) learning, (3) behaviors, and (4) outcomes are considered [
9]. Participant reaction (engagement/satisfaction) was examined through comments provided by the participants. The pre- and post-surveys were used to evaluate learning (knowledge). Behaviors and outcomes were also considered.
The data were analyzed with IBM® SPSS® Statistics Version 26 (Armonk, New York, NY, USA). Mann–Whitney U non-parametric test was used for each separate Likert-style question. A t-test was used for the summary knowledge scores. Significance was set at p < 0.05.
3. Results
The May 2021 TTSTP included 122 healthcare providers from medicine, dentistry, pharmacy, nursing, advanced practice nursing, respiratory therapy, licensed professional counseling, addiction counseling, and social work. Participants who responded to the pre-test were primarily (90.6%) non-Hispanic white participants, female (71.5%), and from the dental field (57.2%). Demographic data were not asked on the post-test. There were 98 (80%) participants who completed the pre-test, and 16 (13%) participants completed the post-test.
Qualitative Results
Three themes emerged from the participants’ comments. These were (1) appreciation for current, evidence-based content—foundational knowledge; (2) perception of increased confidence; and (3) increased skills in pharmacotherapy and combined treatment for tobacco cessation.
3.1. Theme 1: Appreciation
Common participant reactions for appreciation for having current, evidence-based content in the program included statements such as:
“I feel like I have more complete information to offer;”
“I will assess and advise differently;”
“I am more knowledgeable about tobacco cessation.”
“[I] feel more confident talking with my clients on how they can quit;”
“[I will] provide formal tobacco cessation education; prescribe medication for tobacco cessation and perform more thorough counseling;” and
“[I will] be doing more in prescribing; begin actively helping patients with smoking cessation more.”
3.2. Theme 2: Confidence
Common reactions for the second theme (increased confidence) that were evident from participants’ reactions after the program were statements such as:
“[I] feel more confident talking with my clients on how they can quit;”
“[I will] provide formal tobacco cessation education;
prescribe medication for tobacco cessation;
and perform more thorough counseling;” and
“[I will] be more confident in prescribing;
begin actively helping patients with smoking cessation more.”
3.3. Theme 3: Skills
The third theme centered around the participants’ recognition of having increased skills in pharmacotherapy and combined treatment for tobacco cessation. This then was exemplified by statements such as:
“I can now apply evidenced based medicine and safely and efficiently prescribe, to best serve my patients and community;”
“Offer pharmacotherapy;” and
“Recommend combination pharmatherapy [sic].”
For the nine learning/knowledge questions, the mean score on the pre-test was 61.1% (SD: 25.6%), and the median was 66.7% correct. The mean score on the post-test was 87.9% (SD: 14.4%), and the median was 77.8%,
p < 0.001. Details for specific questions are presented in
Table 1.
Table 2 includes the behavioral/outcome comparisons of confidence levels in the skills associated with providing tobacco cessation information, treatment, and support to patients. These included asking about tobacco use, advising quitting, assessing quitting willingness, assisting with quitting, indicating appropriate nicotine replacement treatment to consider, and prescribing a combination therapy. Initially, and at 6 months, the participants were just as likely to ask about tobacco use. Furthermore, all other levels of confidence with these questions improved from the pre-test to the post-test.
Table 3 includes the comparison of the level of skill from the participant’s self-perception of having anywhere from a novice to expert level in their understanding of behavior/outcome. Participants at 6 months were more likely to report “expert” levels of skill in communicating health consequences of tobacco, documenting cessation progress in patient charts, determining individual needs for cessation treatment options, identifying patients who needed medical referrals for cessation, and identifying patients who needed psychological referrals for cessation.
Table 4 includes the responses to current behavioral/outcome practices. The recommendation of nicotine patches was significantly different between the pre-test and post-test, with participants responding more positively to the post-test. There were no significant differences among participants from the pre-survey to the post-survey in asking permission to provide tobacco cessation advice and the utilization of reflections or open-ended questions when counseling patients about tobacco cessation.
4. Discussion
In this study, participants reported significant improvement in knowledge, confidence, and evidence-based practices in managing patients with tobacco cessation on a post-test administered six months following a TTSTP program. Participants were more likely to report being at an expert level in skills associated with tobacco cessation on the post-test as compared with the pre-test. Comments about the skills learned and confidence gained were positive, and the participants expressed appreciation for having had the learning experience.
There is a lack of comparable program evaluation studies related to tobacco cessation programs for healthcare provider interprofessional education. In one similar study of program evaluation, the researcher evaluated a train-the-trainer program [
10]. However, that program was web-based, while the current study was in person. The researcher found the program to be effective for increasing confidence in the pharmacy faculty, and intention to continue to use the curriculum in their courses [
10]. The researcher also reported the program to be effective among participants who provided patient care [
10]. Most participants reported that they asked about tobacco use all or almost all the time; most used motivational interviewing/integrated brief counseling; half provided Quitline cards/numbers, and 41.2% checked for potential smoking-drug interactions when filling prescriptions [
10]. Our study showed participants reported similar results on the post-test.
In another study, researchers used a pre-test/end-of-academic year post-test format to evaluate a 4-h webinar format, an interprofessional faculty train-the-trainer program designed for respiratory therapy faculty [
11]. The emphasis of their program was the preparation of faculty in teaching tobacco cessation. Although our program had many participants who were faculty members and planned to present tobacco cessation information in their classes, the intent of our research was to educate healthcare providers to be competent in providing tobacco cessation treatments for their patients. Our program also differed in length and presentation mode; however, both programs had similar topics for foundational knowledge and patient counseling.
Another tobacco evaluation study was conducted with qualitative methods. The researchers interviewed 18 participants of the Rx for Change: Clinician-Assisted Tobacco Cessation program and reported that participants had increased confidence and counseling skills, enhanced treatment practices, and useful background information even 12–14 years after having participated in the program [
12]. Similar themes were evident in our research. One theme was an appreciation for current, evidence-based content/foundational knowledge, which parallels the theme of useful background information in the Rx for Change study. Our theme of the perception of increased confidence is similar to theirs of increased confidence and counseling skills. Furthermore, our third theme of increased skills in pharmacotherapy and combined treatment for tobacco cessation was similar to theirs of enhanced treatment practices. Our study was also similar to theirs in that both were nationally recognized programs, and both have similar long-term effects. Our study did differ in that we had (1) an interprofessional faculty, (2) interprofessional healthcare participants, (3) an emphasis on established healthcare providers, and (4) our post-survey was distributed 6 months after the program.
In a study in which researchers used a data-driven community-based participatory research approach, online educational modules were created and tested by community leaders and academic researchers [
13]. They conceptualized and developed a curriculum that was culturally specific and met components that addressed ethnic and dispositional community characteristics. Then the researchers conducted a summative evaluation through semi-structured interviews and feedback sessions. Much of the research included qualitative outcomes, which served as the basis for trial and error, flexible planning, and continuous improvement. The current study had a similar approach in which many presenters gathered to develop and present the curriculum to meet the needs of the various healthcare providers. The program was adjusted for responding to participant needs, and lessons were learned in providing a curriculum that had lasting effects.
4.1. Strengths and Limitations
This study has both strengths and limitations. A study limitation is the number of responses received on the post-test. It was sent to participants twice. However, the response rate was low. Reasons for the low response rate include the impact of the COVID-19 pandemic on available healthcare provider time and changes in contact information over the six months of the study. A strength of the study is the use of questions that had been vetted by experts in tobacco treatment to hone in upon the factor that was most important: helping patients to quit tobacco use and maintain being tobacco-free.
4.2. Future Lines of Action
There remains a considerable need to help patients with tobacco cessation. Programs that have summative success, such as this program, are of great importance to public health. They should be supported and expanded into professional healthcare students’ education. Future research should include economic impact based on the number of successful tobacco cessations participants experience after having completed the program.
5. Conclusions
While there was a limited six-month response rate in this study, results showed overwhelming improvement in knowledge, confidence, and skills in managing patients with tobacco cessation. The in-depth, intensive, three-day TTS training program had a lasting impact on those responding healthcare providers’, and some rated themselves at the expert level in many skill areas associated with cessation. More research needs to be completed on the impact of TTS training, particularly as conventional and newer tobacco products continue to flood the market.
Author Contributions
Conceptualization, R.C.W., L.W.S., M.S.G. and S.K.M.; methodology, R.C.W., L.W.S., M.S.G. and S.K.M.; formal analysis, R.C.W.; writing—original draft preparation, R.C.W.; writing—review and editing, R.C.W., L.W.S., M.S.G. and S.K.M. All authors have read and agreed to the published version of the manuscript.
Funding
Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number 5U54GM104942-05. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Institutional Review Board Statement
The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of West Virginia University (protocol code 20039360, 9 April 2020).
Informed Consent Statement
Written informed consent was not obtained as this research study was granted an exemption because the research involves educational tests, survey procedures, interview procedures or observation of public behavior and (i) information obtained is recorded in such a manner that human subjects cannot be identified, directly or through identifiers linked to the subjects; and (ii) any disclosure of the human subjects responses outside the research could not reasonably place the subjects at risk of criminal or civil liability or be damaging to the subjects financial standing, employability, or reputation.
Data Availability Statement
Data sharing is not applicable to this article.
Conflicts of Interest
The authors declare no conflict of interest.
References
- U.S. Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress; A Report of the Surgeon General; U.S. Department of Health and Human Services; Centers for Disease Control and Prevention; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health: Atlanta, GA, USA, 2014.
- Office on Smoking and Health. Achievements in Public Health, 1990–1999: Tobacco Use—United States, 1990–1999. MMWR 1999, 48, 986–993. [Google Scholar]
- Centers for Disease Control and Prevention. Smoking and Tobacco Use Fast Facts and Fact Sheets. Fast Facts and Fact Sheets|Smoking and Tobacco Use|CDC. Available online: https://www.cdc.gov/tobacco/data_statistics/fact_sheets/index.htm (accessed on 1 January 2022).
- Babb, S.; Marlarcher, A.; Schauer, G.; Asman, K.; Manal, A. Quitting Smoking Among Adults-United States, 2000–2015. MMWR Morb. Mortal Wkly Rep. 2017, 65, 1457–1464. [Google Scholar] [CrossRef] [Green Version]
- Cuccia, A.F.; Patel, M.; Amato, M.S.; Stephens, D.K.; Yoon, S.N.; Vallone, D.M. Quitting e-cigarettes: Quit attempts and quit intentions among youth and young adults. Prev. Med. Rep. 2021, 21, 101287. [Google Scholar] [CrossRef] [PubMed]
- Rejewski, A.M.; Bailey, S.R.; Warren, G.W. Considering Systemic Barriers to Treating Tobacco Use in Clinical Settings in the United States. Nicotine Tob. Res. 2019, 21, 1453–1461. [Google Scholar] [CrossRef] [PubMed]
- Schlam, T.R.; Baker, T.B. Interventions for Tobacco Smoking. Annu. Rev. Clin. Psychol. 2013, 9, 675–702. [Google Scholar] [CrossRef] [PubMed]
- Sheffer, C.E.; Payne, T.; Ostroff, J.S.; Jolicoeur, D.; Steinberg, M.; Czabafy, S.; Foulds, J.; Bars, M.; Wassum, K.; Perry, B.; et al. Increasing the Quality and Availability of Evidence-based Treatment for Tobacco Dependence through Unified Certification of Tobacco Treatment Specialists. J. Smok. Cessat. 2014, 11, 229–235. [Google Scholar] [CrossRef] [Green Version]
- Kirkpatrick, D.L. Implementing the Four Levels: A Practical Guide for Effective Evaluation of Training Programs: Easyread Super Large 24pt Edition. Available online: ReadHowYouWant.com (accessed on 28 January 2009).
- El-Khadragy, N.I. Long-term Evaluation of a Shared Tobacco Cessation Curriculum Using a Theory-Based Approach. Ph.D. Thesis, Purdue University Graduate School, West Lafayette, IN, USA, 2020. [Google Scholar]
- Hudmon, K.S.; Vitale, F.M.; Elkhadragy, N.; Corelli, R.L.; Strickland, S.L.; Varekojis, S.M.; Heeg, M.O. Evaluation of an Interprofessional Tobacco Cessation Train-the-Trainer Program for Respiratory Therapy Faculty. Respir. Care 2020, 66, 475–481. [Google Scholar] [CrossRef] [PubMed]
- Elkhadragy, N.; Corelli, R.L.; Russ, A.L.; Snyder, M.E.; Clabaugh, M.; Hudmon, K.S. Faculty perceptions of a tobacco cessation train-the-trainer workshop and experiences with implementation: A qualitative follow-up study. Res. Soc. Adm. Pharm. 2019, 15, 1436–1445. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kwan, P.; Sabado-Liwag, M.; Lee, C.; Lepule, J.; Pang, V.; Pike, J.; Santos, L.; Tanjasiri, S.; Toilolo, T.; May, V.T.; et al. Development of an Online Smoking Cessation Curriculum for Pacific Islanders: A Community-Based Participatory Research Approach. Prog. Community Health Partnersh. Res. Educ. Action 2017, 11, 263–274. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Table 1.
Learning/Knowledge Gained between the Pre-test and Post-test.
Table 1.
Learning/Knowledge Gained between the Pre-test and Post-test.
| Correct | Strongly | | | Strongly | | |
---|
Item | Response | Disagree | Disagree | Neutral | Agree | Agree | p-Value |
---|
One typical cigarette has 1–1.5 mg nicotine | TRUE | | | | | | | | | | | 0.036 |
Pre-test | | 15 | 15.50% | 12 | 12.40% | 21 | 21.60% | 39 | 40.20% | 10 | 10.30% | |
Post-test | | 0 | | 1 | 6.30% | 1 | 6.30% | 3 | 18.80% | 11 | 68.80% | |
One pack of cigarettes typically has 50 cigarettes | FALSE | | | | | | | | | | | 0.036 |
Pre-test | | 60 | 61.90% | 21 | 21.60% | 7 | 7.20% | 8 | 8.20% | 1 | 1.00% | |
Post-test | | 14 | 87.50% | 2 | 12.50% | 0 | | 0 | | 0 | | |
If a person smokes 2 packs of cigarettes a day, according to the Mayo Clinic, it is OK to use two 21 mg nicotine patches at the same time | TRUE | | | | | | | | | | | <0.001 |
Pre-test | | 15 | 15.50% | 24 | 24.70% | 25 | 25.80% | 25 | 25.80% | 8 | 8.20% | |
Post-test | | 0 | | 1 | 6.30% | 1 | 12.50% | 7 | 43.80% | 6 | 37.50% | |
Bupropion SR (Zyban®) should NOT be used in people with liver diseases or prone to seizures | TRUE | | | | | | | | | | | 0.021 |
Pre-test | | 1 | 1.00% | 2 | 2.10% | 28 | 28.90% | 50 | 51.50% | 16 | 16.50% | |
Post-test | | 0 | | 1 | 6.30% | 1 | 6.30% | 7 | 43.80% | 7 | 43.80% | |
The nicotine in one can of some brands of snuff is equal to 4 packs of cigarettes | TRUE | | | | | | | | | | | <0.001 |
Pre-test | | 0 | | 5 | 5.20% | 33 | 34.40% | 49 | 51.00% | 9 | 9.40% | |
Post-test | | 0 | | 0 | | 0 | | 10 | 62.50% | 6 | 37.50% | |
For Bupropion SR (Zyban®) use, a person is still smoking in days 1–7; 150 mg Bupropion is taken once a day in days 1–3; and twice a day (8 h apart) in days 4–7. The person stops smoking in day 8. | TRUE | | | | | | | | | | | 0.175 |
Pre-test | | 4 | 4.20% | 7 | 7.40% | 44 | 46.30% | 37 | 38.90% | 3 | 3.20% | |
Post-test | | 1 | 6.30% | 2 | 12.50% | 4 | 25.00% | 4 | 25.00% | 5 | 32.30% | |
Pack-years is the number of packs of cigarettes smoked per day time the number of years a person smoked | TRUE | | | | | | | | | | | 0.007 |
Pre-test | | 1 | 1.00% | 3 | 3.10% | 10 | 20.80% | 46 | 47.90% | 26 | 27.10% | |
Post-test | | 0 | | 1 | 6.30% | 0 | | 5 | 31.30% | 10 | 62.50% | |
Evidence-based information supports the | | | | | | | | | | | | |
Safety of e-cigarettes | FALSE | | | | | | | | | | | 0.373 |
Pre-test | | 49 | 52.70% | 30 | 32.30% | 13 | 14.00% | 1 | 1.10% | 0 | | |
Post-test | | 10 | 62.50% | 5 | 31.30% | 1 | 6.30% | 0 | | 0 | | |
An individual with tobacco use disorder’s ambivalence toward smoking is addressed in motivational interviewing | TRUE | | | | | | | | | | | 0.007 |
Pre-test | | 1 | 1.10% | 1 | 1.10% | 39 | 41.50% | 42 | 44.70% | 11 | 11.70% | |
Post-test | | 0 | | 1 | 6.30% | 2 | 12.50% | 5 | 31.30% | 8 | 50.00% | |
My team provides a consistent message toward tobacco cessation | | | | | | | | | | | | 0.031 |
Pre-test | | 1 | 1.10% | 7 | 7.40% | 29 | 30.50% | 42 | 44.20% | 16 | 16.80% | |
Post-test | | 0 | | 0 | | 2 | 13.30% | 8 | 53.30% | 5 | 33.30% | |
Mean scores for questions 1–9 | | | | | | | | | | | | <0.001 |
Pre-test | 5.5 (Standard deviation: 2.3) | 61.10% (SD: 25.6%) | Median 6 | 66.70% | | | |
Post-test | 7.9 (Standard deviation: 1.3) | 87.80% (SD: 14.4%) | Median 7 | 77.70% | | | |
Table 2.
Behavioral/outcome practices: Level of Confidence Gained between the Pre-test and Post-test.
Table 2.
Behavioral/outcome practices: Level of Confidence Gained between the Pre-test and Post-test.
| Very Low | Low | Neutral | High | Very High | | |
---|
Item | Confidence | Confidence | Confidence | Confidence | Confidence | N/A | p-Value |
---|
Asking about a person’s tobacco use | | | | | | | | | | | | | 0.055 |
Pre-test | 1 | 1.00% | 2 | 2.10% | 13 | 13.50% | 40 | 41.70% | 34 | 35.40% | 6 | 6.30% | |
Post-test | 0 | | 0 | | 0 | | 5 | 31.30% | 11 | 68.80% | 0 | | |
Advising patients who use tobacco to quit | | | | | | | | | | | | | 0.007 |
Pre-test | 3 | 3.10% | 8 | 8.30% | 30 | 31.30% | 29 | 30.20% | 20 | 20.80% | 6 | 6.30% | |
Post-test | 0 | | 0 | | 1 | 6.30% | 6 | 37.50% | 9 | 56.30% | 0 | | |
Providing tobacco cessation assessment | | | | | | | | | | | | | <0.001 |
Pre-test | 3 | 3.10% | 22 | 22.90% | 38 | 39.60% | 20 | 20.80% | 7 | 7.30% | 6 | 6.30% | |
Post-test | 0 | | 0 | | 1 | 6.30% | 9 | 56.30% | 5 | 31.30% | 1 | 6.30% | |
Assisting a patient to quit tobacco use | | | | | | | | | | | | | <0.001 |
Pre-test | 5 | 5.30% | 20 | 21.1% | 29 | 30.50% | 26 | 27.40% | 9 | 9.50% | 6 | 6.30% | |
Post-test | 0 | | 0 | | 1 | 6.30% | 7 | 43.80% | 7 | 43.80% | 1 | 6.30% | |
Arranging a tobacco cessation program for a patient | | | | | | | | | | | | | <0.001 |
Pre-test | 12 | 12.50% | 25 | 26.00% | 29 | 30.20% | 18 | 18.80% | 6 | 6.30% | 6 | 6.30% | |
Post-test | 0 | 0 | 4 | 25.00% | 8 | 50.00% | 3 | 18.80% | 1 | 6.30% | 0 | | |
Telling patients the appropriate manner or NRT use | | | | | | | | | | | | | 0.001 |
Pre-test | 12 | 12.50% | 25 | 26.00% | 24 | 25.00% | 24 | 25.00% | 4 | 4.20% | 7 | 7.30% | |
Post-test | 0 | | 1 | 6.30% | 2 | 12.50% | 8 | 50.00% | 4 | 25.00% | 1 | 6.30% | |
Prescribing combination therapy | | | | | | | | | | | | | 0.011 |
Pre-test | 20 | 20.80% | 17 | 17.70% | 24 | 25.00% | 13 | 13.50% | 1 | 1.00% | 21 | 21.90% | |
Post-test | 0 | | 2 | 12.50% | 1 | 6.30% | 7 | 43.80% | 2 | 12.50% | 4 | 25.00% | |
Table 3.
Behavioral/outcome practices: Self-Perceived Level of Skill Comparison of Pre-test and Post-test.
Table 3.
Behavioral/outcome practices: Self-Perceived Level of Skill Comparison of Pre-test and Post-test.
Self-Perception |
---|
Item | Novice | Learner | Neutral | Competent | Expert | N/A | p-Value |
---|
Communicating health consequences of tobacco | | | | | | | | | | | | | <0.001 |
Pre-test | 2 | 2.10% | 15 | 15.60% | 22 | 22.90% | 51 | 53.10% | 5 | 5.20% | 1 | 1.00% | |
Post-test | 0 | | 0 | | 0 | | 12 | 75.00% | 4 | 25.00% | 0 | 0 | |
Documenting tobacco cessation progress in patient charts | | | | | | | | | | | | | 0.002 |
Pre-test | 16 | 16.80% | 15 | 15.80% | 29 | 30.50% | 25 | 26.30% | 1 | 1.10% | 9 | 9.50% | |
Post-test | 0 | | 1 | 6.30% | 3 | 18.80% | 6 | 37.50% | 4 | 25.00% | 2 | 12.50% | |
Determining individual-specific appropriate tobacco cessation options | | | | | | | | | | | | | <0.001 |
Pre-test | 15 | 15.80% | 28 | 29.50% | 30 | 31.60% | 17 | 17.90% | 0 | | 5 | 5.30% | |
Post-test | 0 | | 1 | 6.30% | 2 | 12.50% | 9 | 56.30% | 4 | 25.00% | 0 | | |
Identifying risk factors requiring medical referrals for tobacco cessation | | | | | | | | | | | | | 0.004 |
Pre-test | 15 | 15.90% | 28 | 29.50% | 30 | 31.60% | 17 | 17.90% | 0 | | 5 | 5.30% | |
Post-test | 0 | | 1 | 6.30% | 2 | 12.50% | 9 | 56.30% | 4 | 25.00% | 0 | | |
Identifying risk factors requiring referrals for psychological help with tobacco cessation | | | | | | | | | | | | | 0.003 |
Pre-test | 16 | 16.80% | 21 | 22.10% | 32 | 33.70% | 21 | 22.10% | 0 | | 5 | 5.30% | |
Post-test | 0 | | 2 | 12.50% | 3 | 18.80% | 9 | 56.30% | 2 | 12.50% | 0 | | |
Table 4.
Behavioral/outcome practices: Current Practice Changes Between the Pre-test and Post-test.
Table 4.
Behavioral/outcome practices: Current Practice Changes Between the Pre-test and Post-test.
| Very | | | | | | Very | | | | | | |
---|
Item | Low | | Low | | Neutral | | High | | High | | N/A | | p-Value |
---|
I ask permission to provide tobacco cessation advice | | | | | | | | | | | | | 0.313 |
Pre-test | 2 | 2.10% | 7 | 7.30% | 28 | 29.20% | 33 | 34.40% | 14 | 14.60% | 12 | 12.50% | |
Post-test | 0 | | 0 | | 3 | 18.80% | 9 | 56.30% | 2 | 12.50% | 2 | 12.50% | |
I utilize reflective listening when counseling patients | | | | | | | | | | | | | 0.433 |
Pre-test | 1 | 1.00% | 0 | | 24 | 25.00% | 45 | 46.90% | 17 | 17.70% | 9 | 9.40% | |
Post-test | 0 | | 1 | 5.30% | 2 | 12.50% | 7 | 43.80% | 4 | 25.00% | 2 | 12.50% | |
I use open-ended questions when counseling patients | | | | | | | | | | | | | 0.257 |
Pre-test | 1 | 1.10% | 2 | 2.10% | 21 | 22.30% | 44 | 46.80% | 17 | 18.10% | 9 | 9.60% | |
Post-test | 0 | | 0 | | 3 | 18.80% | 6 | 37.50% | 5 | 31.30% | 2 | 12.50% | |
I recommend nicotine patches for tobacco cessation | | | | | | | | | | | | | 0.007 |
Pre-test | 6 | 6.30% | 5 | 5.20% | 37 | 38.50% | 26 | 27.10% | 6 | 6.30% | 16 | 16.70% | |
Post-test | 0 | | 0 | | 2 | 12.50% | 5 | 31.30% | 7 | 43.80% | 2 | 12.50% | |
| Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).